Kw. Small et al., North Carolina macular dystrophy (MCDR1) locus: A fine resolution genetic map and haplotype analysis, MOL VIS, 5(38-40), 1999, pp. NIL_1-NIL_5
Purpose: We previously reported linkage of North Carolina macular dystrophy
in a single isolated family to a broad region on chromosome 6q16. In order
to refine the localization of the MCDR1 gene (North Carolina macular dystr
ophy), additional families with this disease and new markers were studied.
Methods: We ascertained 10 families with the North Carolina macular dystrop
hy phenotype (MCDR1). These families were of various ethnic and geographic
origins such as Caucasian, Mayan Indian, African-American, French, British,
German, and American of European decent. Two hundred thirty-two individual
s in these families underwent comprehensive ophthalmic examinations and blo
od was collected for genotyping. One hundred seventeen were found to be aff
ected. Linkage simulation studies were performed. Two-point linkage, haplot
ype analysis, and multipoint linkage was performed using VITESSE and FASTLI
NK. HOMOG was used to test for genetic heterogeneity.
Results: The clinical features were consistent with the diagnosis of North
Carolina macular dystrophy in all families. Multipoint linkage analysis ind
icates that the MCDR1 gene is in the interval between D6D249 and D6S1671 wi
th a maximum LOD score of 41.52. There was no evidence of genetic heterogen
eity among the families studied. Families 765, 768, 772, 1193, and 1292 sha
red the same chromosomal haplotype in this region.
Conclusions: This is the largest single data set of families with the MCDR1
phenotype. The single large family from North Carolina continues to be inf
ormative for the closest flanking markers and alone supports the minimal ca
ndidate region as suggested by previous studies. There remains no evidence
of genetic heterogeneity in this disease. Most of the American families app
ear to have descended from the same ancestral mutation. The remaining famil
ies could each represent independent origins of the mutation in the MCDR1 g
ene.